Biopsy Cell Cycle Proliferation Score Predicts Adverse Surgical Pathology in Localized Renal Cell Carcinoma
- 1 November 2020
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 78 (5) , 657-660
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The Harms of Overdiagnosis and Overtreatment in Patients with Small Renal Masses: A Mini-reviewEuropean Urology Focus, 2019
- A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell CarcinomaEuropean Urology, 2018
- A Systematic Review of Research Gaps in the Evaluation and Management of Localized Renal MassesUrology, 2016
- Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour BiopsyEuropean Urology, 2016
- Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM RegistryEuropean Urology, 2015
- Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma BiomarkersEuropean Urology, 2014
- Accuracy of Determining Small Renal Mass Management with Risk Stratified Biopsies: Confirmation by Final PathologyJournal of Urology, 2013
- Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney CancerEuropean Urology, 2011